Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Altman Raul"'
Publikováno v:
Thrombosis Journal, Vol 10, Iss 1, p 3 (2012)
Abstract Background Patients with heightened platelet reactivity in response to antiplatelet agents are at an increased risk of recurrent ischemic events. However, there is a lack of diagnostic criteria for increased response to combined aspirin/clop
Externí odkaz:
https://doaj.org/article/16684f1a3c184b0da8cfaf0ec6fa3edf
Autor:
Vidal Hector O, Altman Raul
Publikováno v:
Thrombosis Journal, Vol 9, Iss 1, p 12 (2011)
Abstract Warfarin has a long history of benefit and has become the gold standard medication for the prevention of ischemic stroke in patients with atrial fibrillation. Nevertheless, it is far from perfect and there is no doubt that new drugs must be
Externí odkaz:
https://doaj.org/article/4c52a27fbdbf49078c108588a17057f3
Publikováno v:
Thrombosis Journal, Vol 8, Iss 1, p 8 (2010)
Abstract Background High concentrations of recombinant activated factor VII (rFVIIa) can stop bleeding in hemophilic patients. However the rFVIIa dose needed for stopping haemhorrage in off-label indications is unknown. Since thrombin is the main hem
Externí odkaz:
https://doaj.org/article/4dc9c066bc9c4a3cbe7d9a03074ecee3
Autor:
Altman Raul
Publikováno v:
Thrombosis Journal, Vol 5, Iss 1, p 11 (2007)
Abstract A tendency toward bleeding often undercuts the beneficial preventive effect of higher doses of a single antithrombotic drug or combined antithrombotic therapy. Although high doses of antithrombotic drugs may be necessary for optimal preventi
Externí odkaz:
https://doaj.org/article/5ef6959602124905bfe6e81009efe909
Publikováno v:
Thrombosis Journal, Vol 4, Iss 1, p 5 (2006)
Abstract Background Platelet activation is crucial in normal hemostasis. Using a clotting system free of external tissue factor, we investigated whether activated Factor VII in combination with platelet agonists increased thrombin generation (TG) in
Externí odkaz:
https://doaj.org/article/216e334833e84e659c0fa2ecacff8354
Autor:
Altman Raul
Publikováno v:
Thrombosis Journal, Vol 3, Iss 1, p 7 (2005)
Externí odkaz:
https://doaj.org/article/97262044440e4117a30115f3202fbc5f
Publikováno v:
Thrombosis Journal, Vol 2, Iss 1, p 1 (2004)
Externí odkaz:
https://doaj.org/article/b99cebc8bd254e9da7e6e9dd3c44b9f9
Autor:
Altman Raul
Publikováno v:
Thrombosis Journal, Vol 1, Iss 1, p 4 (2003)
Externí odkaz:
https://doaj.org/article/b04786ea7d584eeebeb7fa0f66cc730d
Autor:
Altman Raul
Publikováno v:
Thrombosis Journal, Vol 1, Iss 1, p 2 (2003)
Abstract Antithrombotic therapy is the cornerstone of the treatment of acute coronary syndromes, but there is now evidence which indicates that by blocking inflammation, thrombosis and thus, acute coronary events, could be lowered. The concept of ath
Externí odkaz:
https://doaj.org/article/940ccb52d77e4edc8efdf3bf05c48d57
Autor:
Altman, Raul1 draltman@arnet.com.ar, Gonzalez, Claudio Daniel2
Publikováno v:
Thrombosis Journal. Aug2015, Vol. 13 Issue 1, p1-5. 5p.